๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II Study of CI-958 in Patients with Hormone Refractory Prostate Carcinoma

โœ Scribed by J. Philip Kuebler; Timothy Moore; James Pritchard; Eric Kraut


Book ID
111579898
Publisher
Springer US
Year
2004
Tongue
English
Weight
44 KB
Volume
22
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Oral estramustine and cyclophosphamide i
โœ Sergio Bracarda; Maurizio Tonato; Paolo Rosi; Verena De Angelis; Ettore Mearini; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

## BACKGROUND. Nearly all cases of metastatic prostate carcinoma progress, after hormonal ablation, to a hormone refractory status. To the authors' knowledge no standard chemotherapy for patients with hormone refractory prostate carcinoma (HRPC) exists. In a prospective study, the efficacy and toxi

Phase II study of CI-958 in colorectal c
โœ Anthony F. Shields; Philip A. Philip; Patricia M. LoRusso; Ann M. Ferris; Mark M ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Springer ๐ŸŒ English โš– 67 KB